Not Signed In - All Topic Areas
1 - 10 of 36 more >>
Clinical Trials
1 - 5 of 197 more >>
- Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00004197 - Active, not recruiting
Lymphoma
- Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection
ClinicalTrials.gov Identifier: NCT00003315 - Active, not recruiting
Infection
- Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
- Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
ClinicalTrials.gov Identifier: NCT00004256 - Active, not recruiting
Laryngeal Cancer
- Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
intraocular melanoma; Melanoma
email this page
print this page
bookmark this page
feedback on this page
